Short Interest in Addus HomeCare Co. (NASDAQ:ADUS) Grows By 36.5%

Addus HomeCare Co. (NASDAQ:ADUS) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 548,700 shares, a growth of 36.5% from the September 15th total of 401,900 shares. Based on an average daily trading volume, of 131,900 shares, the days-to-cover ratio is presently 4.2 days.

Analyst Ratings Changes

A number of research analysts recently weighed in on ADUS shares. StockNews.com downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Oppenheimer lifted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. TD Cowen lifted their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Finally, Stephens reissued an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $131.38.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $130.63 on Friday. The firm has a 50-day moving average of $129.54 and a 200-day moving average of $117.24. The stock has a market cap of $2.36 billion, a PE ratio of 32.41, a P/E/G ratio of 2.33 and a beta of 1.04. Addus HomeCare has a 52-week low of $78.35 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. Addus HomeCare’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.94 EPS. As a group, analysts predict that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insider Activity

In other news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at $429,165. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock worth $3,050,082 over the last quarter. 4.60% of the stock is currently owned by company insiders.

Institutional Trading of Addus HomeCare

Several hedge funds and other institutional investors have recently bought and sold shares of ADUS. UMB Bank n.a. raised its stake in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quest Partners LLC acquired a new stake in Addus HomeCare in the 2nd quarter worth about $31,000. EntryPoint Capital LLC acquired a new stake in Addus HomeCare in the 1st quarter worth about $44,000. Innealta Capital LLC acquired a new stake in Addus HomeCare in the 2nd quarter worth about $44,000. Finally, GAMMA Investing LLC raised its stake in Addus HomeCare by 40.8% in the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock worth $57,000 after purchasing an additional 161 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.